Price target
13.50RUSD+12.49+1,236.63%
The 8 analysts offering 1 year price forecasts for Inozyme Pharma, Inc. have a max estimate of 23.00 and a min estimate of 7.00.
Analyst rating
Based on 9 analysts giving stock ratings to Inozyme Pharma, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
8
Buy
1
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
−0.44
−0.33
−0.22
−0.11
0.00
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
−0.35
−0.29
−0.33
−0.38
−0.44
−0.39
−0.41
—
—
—
—
Estimate
−0.43
−0.32
−0.32
−0.36
−0.40
−0.44
−0.41
−0.41
−0.35
−0.34
−0.33
Surprise
+18.06%
+8.56%
−3.59%
−5.57%
−10.78%
+10.43%
−1.03%
—
—
—
—
Revenue
Forecast
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
0.00
Reported
Estimate
Currency: USD
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Reported
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
—
—
—
Estimate
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Surprise
—
—
—
—
—
—
—
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
INZY EPS for the last quarter is −0.41 USD despite the estimation of −0.41 USD. In the next quarter EPS is expected to reach −0.41 USD. Track more of Inozyme Pharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Inozyme Pharma, Inc. revenue is expected to reach 0.00 USD. Check out Inozyme Pharma, Inc. revenue and earnings and make informed decisions.
According to analysts, INZY price target is 13.50 USD with a max estimate of 23.00 USD and a min estimate of 7.00 USD. Check if this forecast comes true in a year, meanwhile watch Inozyme Pharma, Inc. stock price chart and keep track of the current situation with INZY news and stock market news.
We've gathered opinions of 9 analysts rating INZY stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.